Welcome!

News Feed Item

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

DUBLIN, April 3, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/fz82h5/biomarkers) has announced the addition of the "Biomarkers: Discovery Techniques and Applications - A Global Market Overview" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline, which comprise drug discovery, toxicity, clinical markers of efficacy and therapeutic indicators, development of diagnostic assays and environmental pollutant exposure. The fields of epidemiology and toxicology have also made use of biomarkers in indicating exposure to a range of environmental substances. In such instances, the biomarker could be the substance itself, such as asbestos particles or nicotine-derived nitrosamine ketone (NNK) from tobacco, or a variation of the external substance processed by the body, such as a metabolite. Using biomarkers in species, such as aquatic animals and invertebrates can be helpful in determining levels and ranges of environmental pollutants.

Personalized medicine constitutes another facet that has been in an ever increasing mode, wherein genomic data are utilized for classifying subsets of patients that would respond to a specific line of therapy. The progression of biomarker research in ascertaining the basics of personalized medicine implies that the prospects of jointly developing drugs and biomarkers would be associated with identifying that section of the population that would garner the maximum benefit from that drug treatment. Developing such biomarkers requires expending considerable efforts and resources, which would enable in expanding the tasks accomplished by biomarkers in disease screening as surrogate endpoints and diagnostic indices.

Biomarker discovery techniques analyzed in this report include Bioimaging, Bioinformatics and Omics Technologies. On a broader geographic level, these technologies further drilled down to Bioimaging - Computed Tomography (CT), Magnetic Resonence Imaging (MRI), Ultrasound and Other; and Omics Technologies - Genomics, Metabolomics, Proteomics and Other. The study also explores the global market for therapeutic areas of biomarkers comprising Cardiology, Neurology, Oncology and Other.


Key Topics Covered:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
2. KEY MARKET TRENDS
3. KEY MAJOR PLAYERS
4. KEY BUSINESS TRENDS
5. GLOBAL MARKET OVERVIEW

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW
1. THE UNITED STATES
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK


Companies Mentioned:

  • ACE Biosciences A/S
  • Abbott Laboratories, Inc.
  • Affibody AB
  • Affymetrix, Inc.
  • Agendia N.V.
  • Agilent Technologies, Inc.
  • Altheadx, Inc.
  • Amgen, Inc.
  • Analytical Biological Services Inc.
  • Astrazeneca Plc
  • BG Medicine, Inc.
  • Banyan Biomarkers Inc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis SA
  • Biomérieux SA
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Bruker Corporation
  • Celera Corporation
  • Charles River Laboratories International, Inc.
  • Clarient, Inc.
  • Compugen Ltd.
  • Decode Genetics
  • Dr. Reddy's Laboratories Limited
  • EMD Millipore Corporation
  • Epigenomics AG
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Ltd.
  • Genedata AG
  • Glaxosmithkline, Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Nordion Inc.
  • Novartis AG
  • Perkinelmer Inc.
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC.
  • Philips Healthcare
  • Ranbaxy Laboratories Limited
  • Roche Diagnostics Corporation
  • Rosetta Genomics Ltd.
  • Sanofi
  • Shimadzu Scientific Instruments, Inc
  • Siemens Healthcare
  • Siemens Healthcare Diagnostics, Inc.
  • Sigma-Aldrich Corporation
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc
  • UCB S.A.


For more information visit http://www.researchandmarkets.com/research/fz82h5/biomarker


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
WebRTC sits at the intersection between VoIP and the Web. As such, it poses some interesting challenges for those developing services on top of it, but also for those who need to test and monitor these services. In his session at WebRTC Summit, Tsahi Levent-Levi, co-founder of testRTC, reviewed the various challenges posed by WebRTC when it comes to testing and monitoring and on ways to overcome them.
Internet of @ThingsExpo, taking place June 6-8, 2017 at the Javits Center in New York City, New York, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo New York Call for Papers is now open.
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
"This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Catchpoint Systems, Inc., a provider of innovative web and infrastructure monitoring solutions, has been named “Silver Sponsor” of SYS-CON's DevOps Summit at 18th Cloud Expo New York, which will take place June 7-9, 2016, at the Javits Center in New York City, NY. Catchpoint is a leading Digital Performance Analytics company that provides unparalleled insight into customer-critical services to help consistently deliver an amazing customer experience. Designed ...
WebRTC services have already permeated corporate communications in the form of videoconferencing solutions. However, WebRTC has the potential of going beyond and catalyzing a new class of services providing more than calls with capabilities such as mass-scale real-time media broadcasting, enriched and augmented video, person-to-machine and machine-to-machine communications. In his session at @ThingsExpo, Luis Lopez, CEO of Kurento, introduced the technologies required for implementing these idea...
"A lot of times people will come to us and have a very diverse set of requirements or very customized need and we'll help them to implement it in a fashion that you can't just buy off of the shelf," explained Nick Rose, CTO of Enzu, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Buzzword alert: Microservices and IoT at a DevOps conference? What could possibly go wrong? In this Power Panel at DevOps Summit, moderated by Jason Bloomberg, the leading expert on architecting agility for the enterprise and president of Intellyx, panelists peeled away the buzz and discuss the important architectural principles behind implementing IoT solutions for the enterprise. As remote IoT devices and sensors become increasingly intelligent, they become part of our distributed cloud enviro...
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and containers together help companies achieve their business goals faster and more effectively. In his session at DevOps Summit, Ruslan Synytsky, CEO and Co-founder of Jelastic, reviewed the current landscape of Dev...
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive ad...